Delivery Order SPE2DB22D1017-SPE2DB24FG2AG

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,482,400 units of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $28,782.85 and an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying this critical medication through a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of various medical conditions. The contract has a ceiling value of $32,334.17 and an ultimate completion date of July 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,613.27 and a period of performance ending on February 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,632.54 and a performance period through June 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
This is a $3,141.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a type of medication. The contract has a completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a $1,582.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The order has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as a primary vehicle for providing a comprehensive range of...
This is a $3,539.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication, with a completion date of February 13, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,201.33, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $7,117.20 and an ultimate completion date of March 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, at a ceiling value of $2,395.14. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2AG
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for 4,565,265,315 units of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The order has a ceiling value of $2,054.50 and a completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This order does not utilize a set-aside designation.

Generated 10/25/24, 9:22 AM